Jin Medical International Ltd

Jin Medical International Ltd. is a holding company, which engages in the design, development, manufacture and sale of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The company was founded on January 14, 2020 and is headquartered in Changzhou, China.

Chuzhou City, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or “JinMed”) (NASDAQ: ZJYL), an industrial leader in Assistive Technologies (“AT”), and a manufacturer and developer of wheelchairs and living aids products, today announced the initiation of construction of JinMed's new manufacturing facility at Chuzhou City, Anhui Province, China. JinMed (Anhui) Co., Ltd., a newly established subsidiary of JinMed, will be designated to operate the Chuzhou JinMed plant (the “New Facility”) which is established as an internationally standardized, innovative, and high-end wheelchair and electric wheelchair manufacturing factory. With higher-level production lines in place, more innovative high-quality products are expected to strengthen JinMed's leadership in the AT industry.

Construction of JinMed's New Facility Begins in Chuzhou, China

Jin Medical International Ltd (ZJYL, Financial) experienced a significant stock price increase of 5.04%, reaching $2.71 per share, with a trading volume of 112,221 shares and a turnover rate of 0.07%. The stock's amplitude was recorded at 6.59%.

ZJYL Sees a Stock Surge of 5.04% Amid Positive Financial Performance

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Monday.

Jin Medical International, Nio And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Jin Medical International (NASDAQ: ZJYL ) stock is on the move Thursday as the wheelchair and other living aid products company's shares undergo a split. According to a filing with the Securities and Exchange Commission (SEC), shares of ZJYL stock are undergoing a one-for-20 stock split.

Why Is Jin Medical International (ZJYL) Stock Moving Today?

Carvana

Marathon Digital Holdings

The future of the United States economy appears surprisingly resilient, as evidenced by positive trends in labor force participation, inflation and wages. Despite earlier concerns of long-term scars, the nation has shown remarkable recovery, challenging prevailing pessimism.

Take Profit: 3 Stocks to Sell That Are Up More Than 500% in 2023

Changzhou City, China, Dec. 14, 2023 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or “JinMed”) (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced the signing of a preliminary Memorandum of Understanding (MOU) with Jiangsu Zhongjin Kanglu Information Technology Co., Ltd. ("Zhongjin Kanglu") to acquire all or a partial stake in Zhongjin Kanglu.

JIN MEDICAL INTERNATIONAL LTD. Enters into Memorandum of Understanding to Acquire Medical Equipment Sharing Platform

Changzhou City, China, Dec. 13, 2023 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or “JinMed”) (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced the Company's portable nano-thermal therapy bath has been selected as the equipment for "Lao Le Hui" Assisted Bathing Project (the “Project”). This significant initiative is a collaborative effort between a recognized foundation for the elderly in Shanghai, prominent state-owned enterprises, and industry partners, with the noble purpose of providing compassionate care and assistance to disabled or semi-disabled elderly individuals residing in Shanghai. Over the next two years, the Project aims to serve an impressive goal of 100,000 individuals and train 2,000 dedicated bathing attendants.

JIN MEDICAL INTERNATIONAL LTD. Empowers "Lao Le Hui" Assisted Bathing Project with Portable Nano-thermal Therapy Bath

Changzhou City, China, Dec. 11, 2023 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or “JinMed”) (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced that it has secured orders of RMB 66 million (approximately $9.18 million USD) of their innovative Micro-Hyperbaric Oxygen Chamber equipment (S-type and M-type) from Conlo Industrial Development (Shanghai) CO., LTD. (“Conlo”).

JIN MEDICAL INTERNATIONAL LTD. Secures RMB66 Million in Orders for Innovative Micro-Hyperbaric Oxygen Chamber Equipment

CHANGZHOU, China , Sept. 28, 2023 /PRNewswire/ -- Jin Medical International Ltd.

Jin Medical International Limited Receives NASDAQ Notification Letter Regarding Noncompliance with Continued Listing Rule 5550(a)(3)

CHANGZHOU, China , Aug. 31, 2023 /PRNewswire/ -- Jin Medical International Ltd. ("the Company" or "JinMed") (NASDAQ: ZJYL ) is the world's leading provider of rehabilitation equipment.

Jin Medical (NASDAQ: ZJYL) Expands into the Manufacturing Field of lifestyle Beauty Products, Collaborates in Research and Development of Three Beauty and Body Products, Securing Market Orders

CHANGZHOU, China , Aug. 23, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced its financial results for the six months ended March 31, 2023 ("the period"). Financial and Operational Highlights for Six Months Ended March 31, 2023 Revenues were $10.25 million, representing an 8.3% increase from $9.47 million for the first six months ended March 31, 2022.

Jin Medical International Limited (NASDAQ: ZJYL) Announces Financial Results for Six Months Ended March 31, 2023

CHANGZHOU, China , Aug. 17, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ: ZJYL), the world's leading provider of rehabilitation equipment, rang the bell at the New York Stock Exchange by its Chairman and CEO Wang Erqi on August 17, to celebrate the Company's official listing. JinMed has been publicly traded on the Nasdaq Capital Market since March 28, 2023.

JinMed (NASDAQ: ZJYL) Rings the Nasdaq Stock Market Closing Bell on August 17

CHANGZHOU, China , Aug. 3, 2023 /PRNewswire/ -- Jin Medical International Ltd. ("the Company" or "JinMed") (NASDAQ: ZJYL) which is the world's leading provider of rehabilitation equipment.

JinMed's Nanobathing Products Receive Multiple Patent Certifications and Sign Directed Procurement Agreement with Shanghai Zhongjin HongKang Medical Technology

Changzhou City, China, June 13, 2023 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (the "Company" or “JinMed”) (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today released a new ultralight electric wheelchair model and a new electric mobility vehicle model for the elderly. The two new models have been developed in collaboration with Nanjing Tech University (“NJTech”), which is a top-tier university with over 100 years of history and is well-known for its training programs for engineers in China. JinMed is responsible for the development and manufacturing of the new models' electrical components, while NJTech oversees the new models' style and industrial design. The new models are expected to be ready for sale this year, via multiple sales channels, including online platforms, and authorized dealerships, both in China and overseas markets.

Jin Medical International Ltd. Releases New-Generation Ultralight Portable Electric Wheelchairs and Electric Mobility Vehicles for the Elderly

Changzhou City, China, April 06, 2023 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (the "Company" or “JinMed”) (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced that Prime Number Capital, LLC, as the representative of the underwriters of the Company's initial public offering ("IPO”), has partially exercised the over-allotment option to purchase an additional 47,355 ordinary shares at the IPO price of $8.00 per share. As a result, the Company has raised gross proceeds of $378,840, in addition to the previously announced IPO gross proceeds of $8,000,000, before deducting underwriting discounts and offering expenses.

Jin Medical International Ltd. Announces Exercise of the Underwriters' Over-Allotment Option

Chanson International Holding

Golden Heaven Group Holdings Ltd

Global Mofy Metaverse Ltd

Hitek Global Inc

Himalaya Shipping Ltd

Millennium Group International Holdings Ltd

SYLA Technologies Co Ltd

U Power Ltd

Eight issuers began trading this past week. Six IPOs and one SPAC submitted initial filings this past week.

U.S. IPO Weekly Recap: Q1 IPO Market Wraps Up With 8 Foreign Issuers

Changzhou City, China, March 30, 2023 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (the "Company" or “JinMed”) (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced the closing of its initial public offering (the "Offering") of 1,000,000 ordinary shares (the "Ordinary Shares") at a public offering price of $8.00 per share for total gross proceeds of $8,000,000, before deducting underwriting discounts and offering expenses. In addition, the Company has granted the underwriters an option, within 45 days from the closing date of the Offering, to purchase up to an additional 150,000 Ordinary Shares at the public offering price, less underwriting discounts, to cover over-allotment, if any. The Offering closed on March 30, 2023 and the Ordinary Shares began trading on March 28, 2023 on The Nasdaq Capital Market under the ticker symbol "ZJYL".

Jin Medical International Ltd. Announces Closing of $8,000,000 Initial Public Offering

Changzhou City, China, March 27, 2023 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (the "Company" or “JinMed”) (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced the pricing of its initial public offering (the "Offering") of 1,000,000 ordinary shares (the "Ordinary Shares") at a public offering price of $8.00 per share for total gross proceeds of $8,000,000, before deducting underwriting discounts and offering expenses. The Ordinary Shares have been approved for listing on The Nasdaq Capital Market and are expected to commence trading on March 28, 2023, under the ticker symbol "ZJYL".

Jin Medical International Ltd. Announces Pricing of $8,000,000 Initial Public Offering

Atour Lifestyle Holdings Ltd

Autohome

Alibaba

KE Holdings

Baidu

Kanzhun Ltd

Didi Global

New Oriental Education & Technology Group

Missfresh Ltd

Pinduoduo Inc - ADR

TAL Education Group

Tencent Holdings Limited

Trip.com

UP Fintech Holding

Weibo

The regulatory storm that decimated U.S.-listed Chinese stocks last year is winding down, with shares likely to recover lost ground in 2022. By lowering the threshold for second listings, the Hong Kong Stock Exchange is becoming more attractive to mid-cap U.S.-listed Chinese companies.

U.S.-Listed Chinese Stocks May Be Set For Rebound In 2022

Jin Medical is the first Chinese company using a VIE structure to seek a New York listing since the U.S. securities regulator temporarily banned such applications earlier this year. The wheelchair maker said in its prospectus it believes its application is legally acceptable to various Chinese regulators.

Chinese Wheelchair Maker Tests U.S. Regulator's Appetite For Controversial VIE Structure

Jin Medical International has filed proposed terms for a $27.5 million IPO. The firm sells wheelchairs in Japan, China, and overseas.

News for Jin Medical International Ltd Stock (ZJYL)